Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y B Cheung

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Clinical and Vaccine Immunology : CVI|October 15, 2010
Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine boosterF M Russell, J R Carapetis, C Satzke, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 13, 2015
Understanding domains of health-related quality of life concerns of Singapore Chinese patients with advanced cancer: a qualitative analysisG L Lee, G S Y Pang, R Akhileswaran, et al.
Annals of the Academy of Medicine, Singapore|July 12, 2003
Measuring quality of life in Chinese cancer patients: a new version of the Functional Living Index for Cancer (Chinese)Y B Cheung, G Y Ng, L C Wong, et al.
Annals of the Academy of Medicine, Singapore|July 16, 2005
Concurrent chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the oesophagus: a single centre experienceN S Wong, K F Foo, D Poon, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 2, 2009
Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for controlE L Corbett, T Bandason, Y-B Cheung, et al.
Vaccine|November 4, 2010
Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of ageF M Russell, J R Carapetis, R L Burton, et al.
Journal of Medical Genetics|May 4, 2004
MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic ChineseC G L Lee, K Tang, Y B Cheung, et al.
Vaccine|March 5, 2010
Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancyF M Russell, P V Licciardi, A Balloch, et al.
Vaccine|July 21, 2009
Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccineF M Russell, A Balloch, M L K Tang, et al.
Vaccine|March 9, 2010
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trialF M Russell, J R Carapetis, A Balloch, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Clinical and Vaccine Immunology : CVI|October 15, 2010
Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine boosterF M Russell, J R Carapetis, C Satzke, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 13, 2015
Understanding domains of health-related quality of life concerns of Singapore Chinese patients with advanced cancer: a qualitative analysisG L Lee, G S Y Pang, R Akhileswaran, et al.
Annals of the Academy of Medicine, Singapore|July 12, 2003
Measuring quality of life in Chinese cancer patients: a new version of the Functional Living Index for Cancer (Chinese)Y B Cheung, G Y Ng, L C Wong, et al.
Annals of the Academy of Medicine, Singapore|July 16, 2005
Concurrent chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the oesophagus: a single centre experienceN S Wong, K F Foo, D Poon, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 2, 2009
Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for controlE L Corbett, T Bandason, Y-B Cheung, et al.
Vaccine|November 4, 2010
Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of ageF M Russell, J R Carapetis, R L Burton, et al.
Journal of Medical Genetics|May 4, 2004
MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic ChineseC G L Lee, K Tang, Y B Cheung, et al.
Vaccine|March 5, 2010
Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancyF M Russell, P V Licciardi, A Balloch, et al.
Vaccine|July 21, 2009
Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccineF M Russell, A Balloch, M L K Tang, et al.
Vaccine|March 9, 2010
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trialF M Russell, J R Carapetis, A Balloch, et al.
Pageof 7